SCO-267
CAS: 1656261-09-4
Ref. 3D-BS179509
1mg | 149,00 € | ||
2mg | 223,00 € | ||
5mg | 393,00 € | ||
10mg | 605,00 € | ||
25mg | 1.085,00 € |
Información del producto
SCO-267 is a novel small molecule that has been shown to increase insulin sensitivity in mice by activating the protein kinase Akt3. SCO-267 is orally active and penetrates the blood brain barrier to exert its effects. It has been shown to improve glucose tolerance and insulin sensitivity in wild-type mice, as well as reduce plasma ALT levels in neonatal mice. SCO-267 also activates Akt3 in min6 cells, which are a pancreatic beta cell line. This activation leads to increased fatty acid oxidation and reduced triglyceride accumulation. In knockout mice, SCO-267 was shown to protect against fatty liver disease induced by chronic exposure to ethanol or high fat diet.
Propiedades químicas
Consulta técnica sobre: 3D-BS179509 SCO-267
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.